Anti-inflammatory cholesterol, such as HDL, may also have a more direct effect on viral function above just being associated with an overall higher level of baseline health. Studies have shown HDL particles can actually have an antiviral effect on RNA and DNA viruses, including the RNA virus causing COVID-19. It is thought that HDL has the ability to inactivate the virus, while also acting as an antioxidant, scavenging pathogenic materials and aiding in its removal from the body (4). This ultimately would both prevent infection and improve outcomes if an infection were to occur.
With these interactions between cholesterol and SARS-CoV-2, it leads to the question on if a treatment option can be elucidated from this relationship. Interestingly enough, a possible treatment option has been looked at with promising results. A systematic review and meta-analysis in 2021 confirmed that inpatient hospital use of statin therapy leads to a significant reduction in all-cause mortality in COVID-19 patients (5). It is thought that this benefit could be attributed to the ability of statins to reduce the inflammatory aspect of elevated LDL cholesterol, while possibly even increasing the beneficial HDL.
The COVID-19 pandemic has resulted in a significant amount of research within the medical community, especially regarding lifestyle and nutritional factors of patients. It is well known that those with heart and/or metabolic disease are at higher risk for severe disease and even death if infected. Therefore, when it comes to cholesterol, a potent marker of cardiovascular risk, it is no surprise that a relationship was found. What is surprising however is how cholesterol can have a more direct effect on viral entry into host cells and even against the virus itself. As time goes on, more about this will be understood. In the meantime, understanding ones own cardiovascular risk via at-home cholesterol panel offered by AYUMETRIX can help one understand how their health interplays with their susceptibility to a severe COVID-19 infection.
- Mary Hall, ND, LAc
References:
1. “About Cholesterol.” 2023. Centers for Disease Control and Prevention. https://www.cdc.gov/cholesterol/about.htm
2. Lassale, C., Hamer, M., Hernaez, A., Gale, C.R., Batty, G.D. 2021. Association of pre-pandemic high-density lipoprotein cholesterol with risk of COVID-19 hospitsation and death: the UK Biobank cohort study. medRxiv PrePrint. Online.
3. Tang, Y., Hu, L., Liu, Y., Zhou, B., Qin, X., Ye, J., Shen, M., Wu, Z., Zhang, P. 2021. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci. 18(15): 3533-3543.
4. Kocar, E., Rezen, T., Rozman, D. 2021. Cholesterol, lipoproteins, and COVID-19: basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids. 1866(2): 158849.
5. Vahedian=Azimi, A., Mohammadi, S.M., Benach, M., Beni, F.H., Guest, P.C., Al-Rasadi, K., Jamialahmadi, T., Sahebkar, A. 2021. Improved COVID-19 outcomes following statin therapy: an updated systematic review and meta analysis. Biomed Res Int. 1901772. Online.